One of our two co-founders gave a talk at Dalhousie University on pharmacodynamic biomarkers of hereditary diseases. Dr. Eric Hoffman, PhD, is a human geneticist and translational researcher focused on neuromuscular disease, and skeletal muscle tissue in health and disease. He is currently Associate Dean of Research, School of Pharmacy and Pharmaceutical Sciences, Binghamton University – SUNY. In the private sector, he is co-founder and CEO of ReveraGen Biopharma, co-founder and Vice President of AGADA Biosciences, and co-founder and President of TRiNDS, companies which focus on different aspects of orphan drug development. He is an inventor on nine patents and has authored over 500 publications. He also holds an appointment as Adjunct Professor with the Department of Pharmacology at Dalhousie University.